MRI in High-Grade Glioma Patients Undergoing Chemoradiation
for
High Grade Glioma
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT05212272
Recruiting
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
for
Glioma, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 1 - 21
Code: NCT05555550
Early_phase1, Recruiting
A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
for
High Grade Glioma, Glioblastoma
Location: Chandler AZ, Phoenix AZ
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06072586
Early_phase1, Recruiting
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Window of Opportunity Study of DSP-0390 in Gliomas
for
Glioma, Malignant, IDH Mutation
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT06636162
Early_phase1, Recruiting
Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
for
High Grade Glioma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 10 - 70+
Code: NCT05632562
Early_phase1, Recruiting
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
for
High Grade Glioma, CNS Tumor
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 3
Code: NCT06528691
Phase2, Recruiting
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
for
Recurrent High Grade Glioma
Location: New York NY, Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06126744
Phase1, Recruiting
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM